News

2017 GCRF Walk For A Cure - Thanks For Saving Lives!

The GCRF Walk For A Cure is the largest gathering of GIST Cancer Doctors, researchers, patients and caregivers in the world. It the biggest fundraising event of the year and we depend on your support to continue the fight against this horrific disease. GCRF would like to extend our deepest appreciation to all of the GIST Cancer doctors & researchers who traveled great distances to join us. Thanks also to our spokesman, NBA great, Walt Frazier and to all the volunteers who contributed to making a great event. We couldn’t do this without all of you.

Let’s make the 2018 Walk For A Cure bigger and better than 2017…PLEASE SPREAD THE WORD!

Thank You San Jose!

Thank You San Jose! The GIST Cancer Research Fund in San Jose, California celebrated it’s 10th Year Walking For A Cure. Liz Chew was acknowledged for her time & dedication to the fight against GIST Cancer by Tania and Robert Stuntman, who presented her with a plaque in recognition of this momentous occasion. Our deepest thanks to everyone who attended including Dr. Michael Heinrich from OHSU who attended both the NY and California Walks.


 
Please spread the word regarding GCRF and let's see if we can increase the amount of walkers and donations for 2018!


 

Thank You GCRF
for the Continued Support of
Over $1.3 Million Dollars
to the
OHSU Knight Cancer Institute

The OHSU Knight Cancer Institute
Presented a Thank You Award to
Tania and Robert Stuntman and GCRF by
Michael Heinrich, M.D. & Christopher Corless, M.D., Ph.D.
at the Conference
Highlighting Advancements in
Gastrointestinal Stromal Tumors (GIST) Research
on May 9, 2017.
The GIST Cancer Research Fund has Donated
Over $1,300,000

to the Heinrich-Corless Labs in their research
to find a cure for GIST Cancer.

An Invitation to the Memorial Sloan Kettering Cancer Center GCRF Presentation

 
 
 

 
 
 

Wednesday, May 31, 2017 @ 3:00 pm
Rockefeller Research Laboratories, Room 104
430 East 67th Street, New York, NY 10065

RSVP: Audrey Williams , Friday, March 25
Email: william7@mskcc.org

(Shown left to right): Dr. Tim Bowler, Dr. Ciara Kelly, Dr. Sandra D'Angelo,
Dr. Ping Chi, Dr. William Tap and Dr. Cristina Antonescu, Dr. Ronald DeMatteo missing from photo.

Speakers & Topics:

Ciara Kelly, MD & Tim Bowler, MD, Sarcoma Medical Oncology Service
“The Clinical Impact of Routine Next Generation Sequencing in GIST”

Ping Chi, MD, PhD, HOPP & Sarcoma Medical Oncology Service
“ETV1 Targeting in GIST: On-going and Future Clinical Trials”

Sandra P. D’Angelo, MD, Sarcoma Medical Oncology Service
“An Update on Immune Checkpoint Inhibitors Clinical Trials in GIST”

Ronald DeMatteo, MD, Surgery & Cristina R. Antonescu, MD, Pathology
“The Utility of Patient Material in Guiding the Next Therapeutic Strategy”

Long-Term Survival Rates For GIST Patients


The SWOG study shows strong long-term survival rates for patients with GIST. "This is a really exciting finding," said Dr. Michael Heinrich, a SWOG investigator and a professor of medicine and cell and developmental biology at Oregon Health & Science University, where SWOG is based. SWOG is a global cancer research community of over 12,000 members in 47 states and six foreign countries who design and conduct publicly funded clinical trials. Published in JAMA Oncology.

A Message of Thanks: Jonathan A. Fletcher, MD • Brigham and Women’s Hospital

An update and message of thanks for the GIST Cancer Research Fund from Jonathan A. Fletcher, MD, and his team at Brigham and Women’s Hospital: (in order of appearance) Nacef Bahri, Alexandra Lauria, Meijun Zhu, MD, Bin Li, MD, PhD, Stacy Yanofsky, Armelle Dufresne, MD, PhD, Wenbin Ou, PhD, and Anastasios (Tasos) Kyriazoglou, MD, PhD.

Fox Chase Cancer Center & GCRF

This video highlights advances in research and treatment for Gastrointestinal Stromal Tumors made at Fox Chase Cancer Center in Philadelphia. Fox Chase is grateful to the GIST Cancer Research Fund and its founders, Tania and Robert Stutman, for their generous support. In the video, Martin Belinkey, PhD, Staff Scientist, Lori Rink, PhD, Assistant Professor and Margaret von Mehren, MD, Dept. of Hematology/Oncology share some of the advances made over the past year, as well as what they will pursue in the coming year with this financial support.

The research studies by Martin Belinkey and Lori Rink can be found in the links below:

Somatic loss of function mutations in neurofibromin 1 and MYC associated factor X genes identified by exome-wide sequencing in a wild-type GIST case

Combination of Imatinib Mesylate and AKT Inhibitor Provides Synergistic effects in Preclinical Study of Gastrointestinal Stromal Tumor

Memorial Sloan Kettering Cancer Center - GIST Cancer Research Fund

March 30, 2016

GIST Education Conference & Lunch • Portland, Oregon

OSHU_group

The 2016 GCRF Conference and Luncheon at Oregon Health and Science University’s Knight Cancer Institute was held on May 10, 2016. The labs of Dr. Michael Heinrich, Dr. Christopher Corliss and Dr. Brian Druker are relentless in their dedication to advancing treatment options for patients with gastrointestinal stromal tumors (GIST) and other cancers. The teams are actively working on a variety of projects that are yielding promising results:
The search for a master key
Strategies to decrease KIT production
Identifying new types of GIST
Establishing model systems for SDH-deficient GIST to test new strategies

Dr. Michael Heinrich gave a presentation which include a review of the the projects he and his team of researchers are currently working on at OHSU.

We would like to extend our sincere gratitude to everyone who participated in the 2016 Annual GCRF Conference and Luncheon. It was wonderful to see so many of you and we hope you found a sense of community, patient support and helpful information at this event. Additionally, we want to thank the GCRF for their incredibly generous donation. With your amazing fundraising efforts, we are able to continue to work hard to find a cure for this devastating disease.

OSHU_group

Please click on the following link to view the presentations from the Conference: